Actuate Therapeutics (ACTU) Institutional Ownership $6.88 -1.63 (-19.15%) Closing price 04:00 PM EasternExtended Trading$6.76 -0.12 (-1.73%) As of 04:33 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Actuate Therapeutics (NASDAQ:ACTU)Number ofInstitutional Buyers(last 12 months)17TotalInstitutional Inflows(last 12 months)$83.19MNumber ofInstitutional Sellers(last 12 months)0 Get ACTU Insider Trade Alerts Want to know when executives and insiders are buying or selling Actuate Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data ACTU Institutional Buying and Selling by Quarter Actuate Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/15/2025Bank of America Corp DE15,292$93K0.0%+61,068.0%0.075% 8/14/2025Voss Capital LP286,140$1.75M0.1%+101.0%1.398% 8/13/2025New York State Common Retirement Fund17,200$105K0.0%N/A0.084% 8/13/2025Northwestern Mutual Wealth Management Co.18,518$113K0.0%+492.6%0.090% 8/12/2025BIOS Capital Management LP9,965,079$60.89M83.9%+0.7%48.681% 8/12/2025Sfmg LLC14,550$89K0.0%+32.3%0.071% 8/8/2025Geode Capital Management LLC118,050$721K0.0%+252.5%0.577% 7/17/2025Gleason Group Inc.19,028$116K0.0%N/A0.097% 6/27/2025Goldman Sachs Group Inc.22,358$151K0.0%+98.7%0.114% 5/16/2025Goldman Sachs Group Inc.22,358$151K0.0%+98.7%0.114% 5/14/2025Voss Capital LP142,381$964K0.1%+157.7%0.729% 5/9/2025Chicago Partners Investment Group LLC10,365$70K0.0%N/A0.053% 5/9/2025Sfmg LLC11,000$74K0.0%N/A0.056% 5/2/2025Sigma Planning Corp23,675$160K0.0%+47.3%0.121% 2/17/2025OMERS ADMINISTRATION Corp10,583$84K0.0%N/A0.054% 2/14/2025Mercer Global Advisors Inc. ADV16,344$130K0.0%N/A0.084% 2/14/2025Voss Capital LP55,246$440K0.0%N/A0.283% 2/13/2025Envestnet Asset Management Inc.10,465$83K0.0%N/A0.054% 2/10/2025BIOS Capital Management LP9,893,651$78.75M83.7%N/A50.659% 2/6/2025Freestone Capital Holdings LLC10,000$80K0.0%N/A0.051% 2/3/2025Sigma Planning Corp16,075$128K0.0%N/A0.082% 11/12/2024Northwestern University27,778$207K0.2%N/A0.142% 10/29/2024KG&L Capital Management LLC12,000$89K0.0%N/A0.061% (Data available from 1/1/2016 forward) ACTU Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ACTU shares? During the previous two years, 17 institutional investors and hedge funds held shares of Actuate Therapeutics. The most heavily invested institutionals were BIOS Capital Management LP ($60.89M), Voss Capital LP ($1.75M), Geode Capital Management LLC ($721K), Northwestern University ($207K), Sigma Planning Corp ($160K), Goldman Sachs Group Inc. ($151K), and Mercer Global Advisors Inc. ADV ($130K).Learn more on Actuate Therapeutics' institutional investors. Which institutional investors have been buying Actuate Therapeutics' stock? Of the 17 institutional investors that purchased Actuate Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: BIOS Capital Management LP ($9.97M), Voss Capital LP ($286.14K), Geode Capital Management LLC ($84.56K), Northwestern University ($27.78K), Sigma Planning Corp ($23.68K), Goldman Sachs Group Inc. ($22.21K), and Gleason Group Inc. ($19.03K). How much institutional buying is happening at Actuate Therapeutics? Institutional investors have bought a total of 10,560,638 shares in the last 24 months. This purchase volume represents approximately $83.19M in transactions. Related Companies OCS Institutional Ownership KALV Institutional Ownership NRIX Institutional Ownership TBPH Institutional Ownership GHRS Institutional Ownership VALN Institutional Ownership VIR Institutional Ownership KURA Institutional Ownership SANA Institutional Ownership MNMD Institutional Ownership This page (NASDAQ:ACTU) was last updated on 9/10/2025 by MarketBeat.com Staff From Our PartnersThis stock just surpassed PalantirThe media hasn't caught up to the story yet, but when they do, this stock could leave Nvidia in the dust. I...InvestorPlace | SponsoredOne tiny company just cracked Google’s $19B problemTucked away outside San Antonio sits a facility most Americans don’t know exists. It’s not mining gold or o...True Market Insiders | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredAlert: Prepare for Trump's Dollar OverhaulPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredTrump’s reported death a hoaxHow Trump’s latest policies could trigger a full-scale debt collapse… And the specific investments that cou...Porter & Company | SponsoredWorld War 3? Everything Just Changed — and One Tiny Company Is at the Center of It.Trump immediately activated a $5.3 TRILLION AI missile shield — code-named Golden Dome — to stop drone swarms ...Angel Publishing | SponsoredLitecoin’s Creator Backs the World’s First TreasuryBitcoin's corporate adoption story has been written. Litecoin's is just beginning.The Tomorrow Investor | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Actuate Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Actuate Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
